@article{486f68ba3c2742d7be52892d1d8b13bd,
title = "Castration-resistant prostate cancer: Where we stand in 2013 and what urologists should know",
author = "Axel Heidenreich and David Pfister and Axel Merseburger and Georg Bartsch",
note = "Funding Information: Axel Heidenreich has received honoraria from Astellas, Amgen, Dendreon, Ferring, IPSEN, Jansen Cilag, Sanofi Aventis, and Takeda, and he has received research grants from Astellas and Sanofi Aventis. David Pfister has received honoraria from Astellas, IPSEN, Jansen Cilag, and Sanofi Aventis. Axel Merseburger has received honoraria from Astellas, IPSEN, Jansen Cilag, and Sanofi Aventis. Georg Bartsch has nothing to disclose. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2013",
month = aug,
doi = "10.1016/j.eururo.2013.05.021",
language = "English",
volume = "64",
pages = "260--265",
journal = "European Urology",
issn = "0302-2838",
number = "2",
}
